Table 1

Summary of the quality statements and percentage adherence

Quality statements for clinically significant bronchiectasis in adultsAdherence (%)
People with a clinical diagnosis of bronchiectasis have the diagnosis confirmed by chest CT scan (using 1 mm slices)91
People with bronchiectasis are taught appropriate airway clearance techniques by a specialist respiratory physiotherapist and advised of the frequency and duration with which these should be carried out78
People with bronchiectasis have sputum bacteriology culture when clinically stable recorded at least once each year62
Sputum is sent for bacterial culture at the start of an exacerbation before starting antibiotics. Empirical antibiotic treatment to start as soon as feasible and not await the sputum culture results53
People with bronchiectasis to attend pulmonary rehabilitation if they have breathlessness affecting their activities of daily living32
People with bronchiectasis receiving intravenous antibiotic treatment to have an objective evaluation of the efficacy of their treatment and the result recorded78
Services for people with bronchiectasis to include provision of nebulised prophylactic antibiotics for suitable patients supervised by a respiratory specialist94
People with bronchiectasis to be investigated for allergic bronchopulmonary aspergillosis, common variable immunodeficiency and cystic fibrosis (the last of these if indicated) as these are specific treatable causes16–68
People with bronchiectasis to have an individualised written self-management plan33
People with bronchiectasis who meet the criteria for continuing secondary care to be managed by a multidisciplinary team led by a respiratory physician94
Services for people with bronchiectasis to include provision of home intravenous antibiotic treatment for exacerbations in selected patients40